Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
Acer Therapeutics Inc. (ACER)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (including intangibles) | 292.0% | | 300.3% | | -761.5% | -413.9% | -395.1% | -186.6% |
| ROE | 166.2% | | 858.6% | | -277.3% | -162.7% | -48.2% | -62.4% |
| ROA | -239.7% | | -40.8% | | -156.0% | -139.3% | -42.9% | -57.2% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | | | 0.0 | | | | | |
| Days payables outstanding | | | | | | | | |
| Cash conversion cycle | | | | | | | | |
|